Cumberland Pharmaceuticals Inc (CPIX) Stock Price

CPIXStock

$8.70+138.30%52W

Market Cap$130.35M

P/E—

PEG Ratio1.67

Div yield—

Beta0.07

CPIX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)88.75%

Price vs S&P 500 (4W)12.07%

PEG Ratio1.67

VGM Score52.56

P/CF (Annual)24.00x

Book Value / Share (Quarterly)$1.44

P/TBV (Annual)5.49x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1.95%

Cash Flow / Share (Quarterly)$0.09

Price vs S&P 500 (YTD)85.03%

Gross Margin (TTM)82.89%

Net Profit Margin (TTM)-17.26%

EPS (TTM)$-0.49

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-0.49

Revenue Growth (5Y)3.53%

EPS (Annual)$-0.19

ROI (Annual)-9.42%

Gross Margin (Annual)85.02%

Net Profit Margin (5Y Avg)-12.47%

Cash / Share (Quarterly)$0.73

Revenue Growth QoQ (YoY)-22.04%

ROA (Last FY)-3.69%

Revenue Growth TTM (YoY)2.08%

EBITD / Share (TTM)$-0.20

ROE (5Y Avg)-16.90%

Operating Margin (TTM)-17.20%

Cash Flow / Share (Annual)$0.32

P/B Ratio5.47x

P/B Ratio (Quarterly)2.25x

Net Income / Employee (Annual)$-30,500

EV / Revenue (TTM)2.68x

Net Interest Coverage (TTM)-145.11x

ROA (TTM)-10.28%

EV / EBITDA (TTM)90.61x

EPS Incl Extra (Annual)$-0.19

Current Ratio (Annual)1.01x

Quick Ratio (Quarterly)0.73x

3-Month Avg Trading Volume0.72M

52-Week Price Return138.30%

EV / Free Cash Flow (Annual)23.70x

Revenue / Employee (TTM)$451,000

Tangible BV / Share (Quarterly)$0.59

P/S Ratio (Annual)2.66x

Asset Turnover (Annual)0.58x

52-Week High$8.45

Operating Margin (5Y Avg)-16.47%

EPS Excl Extra (Annual)$-0.19

CapEx CAGR (5Y)-38.72%

Tangible BV CAGR (5Y)-10.50%

26-Week Price Return100.00%

Quick Ratio (Annual)0.77x

13-Week Price Return42.29%

Total Debt / Equity (Annual)0.21x

Current Ratio (Quarterly)0.95x

Enterprise Value$112.60M

Revenue / Share Growth (5Y)3.95%

Asset Turnover (TTM)0.60x

Book Value / Share Growth (5Y)-11.89%

Revenue / Employee (Annual)$478,700

Inventory Turnover (Annual)1.30x

Pretax Margin (Annual)-6.31%

Cash / Share (Annual)$0.77

3-Month Return Std Dev76.78%

Gross Margin (5Y Avg)82.24%

Net Income / Employee (TTM)$-77,800

ROE (Last FY)-11.40%

Net Interest Coverage (Annual)-156.38x

EPS Basic Excl Extra (Annual)$-0.19

P/FCF (TTM)89.25x

Receivables Turnover (TTM)3.39x

EV / Free Cash Flow (TTM)87.60x

Total Debt / Equity (Quarterly)0.24x

EPS Incl Extra (TTM)$-0.49

Receivables Turnover (Annual)3.11x

ROI (TTM)-23.81%

P/S Ratio (TTM)2.82x

Pretax Margin (5Y Avg)-13.61%

Revenue / Share (Annual)$3.00

Tangible BV / Share (Annual)$0.73

Free OCF CAGR (5Y)7.49%

Price vs S&P 500 (52W)119.99%

Year-to-Date Return96.98%

5-Day Price Return2.75%

EPS Normalized (Annual)$-0.19

ROA (5Y Avg)-6.02%

Net Profit Margin (Annual)-6.37%

Month-to-Date Return17.37%

Cash Flow / Share (TTM)$0.12

EBITD / Share (Annual)$0.09

Operating Margin (Annual)-6.27%

LT Debt / Equity (Annual)0.21x

P/CF (TTM)83.30x

ROI (5Y Avg)-11.58%

LT Debt / Equity (Quarterly)0.24x

EPS Basic Excl Extra (TTM)$-0.49

P/TBV (Quarterly)5.50x

P/B Ratio (Annual)2.39x

Inventory Turnover (TTM)1.50x

Pretax Margin (TTM)-17.17%

Book Value / Share (Annual)$1.66

Price vs S&P 500 (13W)39.49%

Beta0.07x

P/FCF (Annual)24.92x

Revenue / Share (TTM)$2.80

ROE (TTM)-28.77%

52-Week Low$1.85

vGradeD

gGradeC

mGradeB

vgmGradeC

CPIX Earnings Surprise History

Q3 200.02est. -0.07

Q4 200.01est. -0.01

Q1 210.07est. -0.07

Q2 21-0.00est. -0.07

CPIX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.17

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
CPIXCumberland Pharmaceuticals Inc	D	C	B	$8.70
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes branded prescription drugs targeting hospital acute care, gastroenterology, rheumatology, and oncology. The company generates revenue from its portfolio of FDA-approved brands including Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol, and Vibativ, which it distributes through dedicated US sales divisions and international partner networks.